Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is independently associated with obesity and cardiovascular disease (CVD). CVD is the primary cause of mortality in the predominantly obese population of adults with NAFLD. NAFLD is increasingly seen in individuals who are lean and overweight (i.e., nonobese)...
Main Authors: | Arvind, A. (Author), Balogun, O. (Author), Chung, R.T (Author), Corey, K.E (Author), Donovan, A. (Author), Henson, J.B (Author), Memel, Z.N (Author), Nath, C. (Author), Osganian, S.A (Author), Simon, T.G (Author), Steinhagen, L.M (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
John Wiley and Sons Inc
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
by: Corey, K.E, et al.
Published: (2022) -
Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
by: Eun Jeong Kim, et al.
Published: (2019-01-01) -
Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01) -
Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
by: Anna Jeznach-Steinhagen, et al.
Published: (2019-05-01) -
Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study
by: Zhenya Lu, et al.
Published: (2016-01-01)